Craft

NATCO Pharma

Stock Price

₹1.3 K

2024-10-29

Market Capitalization

₹245.7 B

2024-10-29

Revenue

₹39.8 B

FY, 2024

NATCO Pharma Summary

Company Summary

Overview
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). It specializes in generic oncology.
Type
Public
Status
Active
Founded
1981
HQ
Hyderabad, IN | view all locations
Website
https://www.natcopharma.co.in/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • M. Pulla Reddy

    M. Pulla Reddy, Executive Vice President - R&D

    • Leela Digumarti

      Leela Digumarti, Independent Director

      • Linga Rao

        Linga Rao, President - Technical Affairs

        • Appa Rao S V V N, Chief Financial Officer

          LocationsView all

          7 locations detected

          • Hyderabad, Telangana HQ

            India

            Natco House, Road No-2, Banjara Hills, Park View Enclave, Jubilee Hills

          • Central Hope Town, UK

            India

            Pharma City Rd

          • Chennai, TN

            India

            Tpp salai, 74/7b, SH 104, Vaikkadu, Block 270 Manali New Town, Manali

          • Hyderabad, TG

            India

            Unnamed Road, Sanath Nagar IE, Sanath Nagar

          • Santola, AS

            India

            Mirza Chowk, Mirza

          • Vijayapuri North, TG

            India

            H8M7+X6P

          and 1 others

          NATCO Pharma Financials

          Summary Financials

          Revenue (Q2, 2025)
          ₹13.7B
          Gross profit (Q2, 2025)
          ₹12.6B
          Net income (Q2, 2025)
          ₹6.8B
          Cash (Q2, 2025)
          ₹15.6B
          EBIT (Q2, 2025)
          ₹8.2B
          Enterprise value
          $232.2B

          Footer menu